• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共病对英国初级保健费用的影响:一项回顾性观察研究。

Implications of comorbidity for primary care costs in the UK: a retrospective observational study.

机构信息

Centre for Academic Primary Care, School of Social and Community Medicine, University of Bristol, Bristol, UK.

出版信息

Br J Gen Pract. 2013 Apr;63(609):e274-82. doi: 10.3399/bjgp13X665242.

DOI:10.3399/bjgp13X665242
PMID:23540484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3609475/
Abstract

BACKGROUND

Comorbidity is increasingly common in primary care. The cost implications for patient care and budgetary management are unclear.

AIM

To investigate whether caring for patients with specific disease combinations increases or decreases primary care costs compared with treating separate patients with one condition each.

DESIGN

Retrospective observational study using data on 86 100 patients in the General Practice Research Database.

METHOD

Annual primary care cost was estimated for each patient including consultations, medication, and investigations. Patients with comorbidity were defined as those with a current diagnosis of more than one chronic condition in the Quality and Outcomes Framework. Multiple regression modelling was used to identify, for three age groups, disease combinations that increase (cost-increasing) or decrease (cost-limiting) cost compared with treating each condition separately.

RESULTS

Twenty per cent of patients had at least two chronic conditions. All conditions were found to be both cost-increasing and cost-limiting when co-occurring with other conditions except dementia, which is only cost-limiting. Depression is the most important cost-increasing condition when co-occurring with a range of conditions. Hypertension is cost-limiting, particularly when co-occurring with other cardiovascular conditions.

CONCLUSION

Three categories of comorbidity emerge, those that are: cost-increasing, mainly due to a combination of depression with physical comorbidity; cost-limiting because treatment for the conditions overlap; and cost-limiting for no apparent reason but possibly because of inadequate care. These results can contribute to efficient and effective management of chronic conditions in primary care.

摘要

背景

共病在基层医疗中越来越常见。其对患者护理和预算管理的成本影响尚不清楚。

目的

调查与分别治疗每位患者的单一病症相比,治疗特定疾病组合的患者是否会增加或降低基层医疗成本。

设计

使用一般实践研究数据库中 86100 名患者的数据进行回顾性观察研究。

方法

为每位患者估算了年度基层医疗成本,包括咨询、药物和检查。共病患者被定义为在质量和结果框架中当前患有一种以上慢性疾病的患者。多元回归模型用于确定在三个年龄组中,与单独治疗每种疾病相比,哪些疾病组合会增加(成本增加)或减少(成本限制)成本。

结果

20%的患者至少患有两种慢性疾病。除痴呆症外,所有疾病与其他疾病同时发生时,均被发现既会增加成本又会限制成本,痴呆症仅会限制成本。当与一系列疾病同时发生时,抑郁症是最重要的成本增加疾病。高血压是成本限制因素,特别是当与其他心血管疾病同时发生时。

结论

出现了三类共病,分别是:成本增加,主要是由于抑郁症与身体共病的结合所致;由于治疗重叠而成本限制;以及由于护理不足或其他原因而成本限制。这些结果有助于在基层医疗中有效管理慢性病。

相似文献

1
Implications of comorbidity for primary care costs in the UK: a retrospective observational study.共病对英国初级保健费用的影响:一项回顾性观察研究。
Br J Gen Pract. 2013 Apr;63(609):e274-82. doi: 10.3399/bjgp13X665242.
2
Determining the cost of obesity and its common comorbidities from a commercial claims database.从商业理赔数据库确定肥胖症及其常见合并症的成本。
Clin Obes. 2014 Feb;4(1):53-8. doi: 10.1111/cob.12041. Epub 2013 Nov 22.
3
Caring for People With Depression: Costs Among 43 Million Commercially Insured Patients With or Without Comorbid Illnesses.照顾抑郁症患者:有或无共病的 4300 万商业保险患者的成本。
Ann Behav Med. 2023 Apr 22;57(5):380-385. doi: 10.1093/abm/kaac063.
4
Associations between untreated depression and secondary health care utilization in patients with hypertension and/or diabetes.未治疗的抑郁症与高血压和/或糖尿病患者的二级保健利用之间的关联。
Soc Psychiatry Psychiatr Epidemiol. 2019 Feb;54(2):255-276. doi: 10.1007/s00127-018-1545-7. Epub 2018 Jun 15.
5
Prevalence and costs of treating uncomplicated stage 1 hypertension in primary care: a cross-sectional analysis.基层医疗中单纯性1期高血压的患病率及治疗费用:一项横断面分析。
Br J Gen Pract. 2014 Oct;64(627):e641-8. doi: 10.3399/bjgp14X681817.
6
Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study.美国大型医疗保健系统员工出勤主义数据四年回顾:一项回顾性患病率研究。
Hum Resour Health. 2018 Nov 9;16(1):59. doi: 10.1186/s12960-018-0321-9.
7
Medical care expenditures for hypertension, its complications, and its comorbidities.用于治疗高血压、其并发症及合并症的医疗费用。
Med Care. 2001 Jun;39(6):599-615. doi: 10.1097/00005650-200106000-00008.
8
Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.协作式照护(与常规照护相比)对伴有抑郁症及共病糖尿病或心血管疾病患者的长期成本效益:一项基于COINCIDE随机对照试验的马尔可夫模型研究
BMJ Open. 2016 Oct 7;6(10):e012514. doi: 10.1136/bmjopen-2016-012514.
9
The prevalence of chronic conditions and medical expenditures of the elderly by chronic condition indicator (CCI).按慢性病指标(CCI)划分的老年人慢性病患病率和医疗支出。
Arch Gerontol Geriatr. 2011 May-Jun;52(3):284-9. doi: 10.1016/j.archger.2010.04.017. Epub 2010 May 10.
10
[Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].[2007年波兰多中心研究中慢性阻塞性肺疾病加重期在初级和二级医疗保健中的费用]
Pol Merkur Lekarski. 2009 Mar;26(153):208-14.

引用本文的文献

1
Quantifying cost and health-related quality of life outcomes in different multimorbidity trajectories: a systematic review protocol.量化不同多重疾病轨迹中的成本和健康相关生活质量结果:一项系统评价方案
BMJ Open. 2025 Aug 24;15(8):e102096. doi: 10.1136/bmjopen-2025-102096.
2
Temporal Relationship Between Treatment Burden and Self-Care and Its Impact on Systolic Blood Pressure and Hypertension Control.治疗负担与自我护理之间的时间关系及其对收缩压和高血压控制的影响。
Int J Gen Med. 2025 Jul 1;18:3597-3607. doi: 10.2147/IJGM.S517281. eCollection 2025.
3
Economic burden of cardiovascular disease in the United Kingdom.英国心血管疾病的经济负担。
Eur Heart J Qual Care Clin Outcomes. 2025 Aug 11;11(5):678-690. doi: 10.1093/ehjqcco/qcaf011.
4
The effect of different levels of systolic blood pressure control on new-onset chronic kidney disease in hypertension multimorbidity.不同水平的收缩压控制对高血压多种疾病中新发慢性肾脏病的影响。
Sci Rep. 2024 Aug 27;14(1):19858. doi: 10.1038/s41598-024-71019-9.
5
Multimorbidity healthcare expenditure in Belgium: a 4-year analysis (COMORB study).比利时多病种医疗支出研究:一项为期 4 年的分析(COMORB 研究)。
Health Res Policy Syst. 2024 Mar 22;22(1):35. doi: 10.1186/s12961-024-01113-x.
6
The effects of medical comorbidity, cognition, and age on patient-reported outcomes in Parkinson's disease.医学合并症、认知功能和年龄对帕金森病患者报告结局的影响。
Parkinsonism Relat Disord. 2023 Nov;116:105892. doi: 10.1016/j.parkreldis.2023.105892. Epub 2023 Oct 10.
7
Uncontrolled blood pressure and therapeutic inertia in treated hypertensive patients: A retrospective cohort study using a UK general practice database.未经控制的血压和治疗惰性在治疗的高血压患者中:使用英国一般实践数据库的回顾性队列研究。
J Clin Hypertens (Greenwich). 2023 Oct;25(10):895-904. doi: 10.1111/jch.14699. Epub 2023 Sep 22.
8
Interaction of mental comorbidity and physical multimorbidity predicts length-of-stay in medical inpatients.精神共病与躯体多病共存相互作用预测内科住院患者的住院时间。
PLoS One. 2023 Jun 22;18(6):e0287234. doi: 10.1371/journal.pone.0287234. eCollection 2023.
9
Trends and all-cause mortality associated with multimorbidity of non-communicable diseases among adults in the United States, 1999-2018: a retrospective cohort study.美国成年人非传染性疾病合并症的趋势和全因死亡率:一项回顾性队列研究。
Epidemiol Health. 2023;45:e2023023. doi: 10.4178/epih.e2023023. Epub 2023 Feb 14.
10
The Costs of Dementia in Europe: An Updated Review and Meta-analysis.欧洲的痴呆症成本:一项更新的综述和荟萃分析。
Pharmacoeconomics. 2023 Jan;41(1):59-75. doi: 10.1007/s40273-022-01212-z. Epub 2022 Nov 15.

本文引用的文献

1
Keep it simple? Predicting primary health care costs with clinical morbidity measures.保持简单?用临床发病率指标预测初级医疗保健成本。
J Health Econ. 2014 May;35(100):109-22. doi: 10.1016/j.jhealeco.2014.02.005. Epub 2014 Mar 2.
2
Managing patients with mental and physical multimorbidity.管理患有精神和身体多种疾病的患者。
BMJ. 2012 Sep 3;345:e5559. doi: 10.1136/bmj.e5559.
3
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.共病的流行病学及其对医疗保健、研究和医学教育的影响:一项横断面研究。
Lancet. 2012 Jul 7;380(9836):37-43. doi: 10.1016/S0140-6736(12)60240-2. Epub 2012 May 10.
4
Review: health care utilization and costs of elderly persons with multiple chronic conditions.综述:患有多种慢性病的老年人的医疗保健利用和费用。
Med Care Res Rev. 2011 Aug;68(4):387-420. doi: 10.1177/1077558711399580.
5
The prevalence of multimorbidity in primary care and its effect on health care utilization and cost.基层医疗中多病共存的流行情况及其对医疗保健利用和成本的影响。
Fam Pract. 2011 Oct;28(5):516-23. doi: 10.1093/fampra/cmr013. Epub 2011 Mar 24.
6
Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study.基层医疗中多种共病的流行病学和影响:一项回顾性队列研究。
Br J Gen Pract. 2011 Jan;61(582):e12-21. doi: 10.3399/bjgp11X548929.
7
Prevalence and outcomes of use of potentially inappropriate medicines in older people: cohort study stratified by residence in nursing home or in the community.老年人中潜在不适当药物使用的流行率和结局:按居住在养老院或社区分层的队列研究。
BMJ Qual Saf. 2011 Mar;20(3):275-81. doi: 10.1136/bmjqs.2009.039818. Epub 2011 Jan 5.
8
Healthcare costs in patients with diabetes mellitus and comorbid mental disorders--a systematic review.患有糖尿病和合并精神障碍的患者的医疗保健费用——系统评价。
Diabetologia. 2010 Dec;53(12):2470-9. doi: 10.1007/s00125-010-1873-y. Epub 2010 Aug 11.
9
How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice.共病如何影响肠易激综合征患者的医疗保健费用?一般实践中的队列研究。
BMC Gastroenterol. 2010 Mar 17;10:31. doi: 10.1186/1471-230X-10-31.
10
Validity of diagnostic coding within the General Practice Research Database: a systematic review.全科医学研究数据库中诊断编码的有效性:系统评价。
Br J Gen Pract. 2010 Mar;60(572):e128-36. doi: 10.3399/bjgp10X483562.